Vai al contenuto principale della pagina
Titolo: | Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017 |
Pubblicazione: | Washington : , : U.S. Government Publishing Office, , 2018 |
Descrizione fisica: | 1 online resource (iv, 51 pages) |
Soggetto topico: | Drugs - United States - Testing |
Drug approval - United States | |
Drugs - Safety regulations - United States | |
Medical instruments and apparatus - Safety regulations - United States | |
Generic drugs - United States | |
Competition - United States | |
Antitrust law - United States | |
Antitrust law | |
Competition | |
Drug approval | |
Drugs - Safety regulations | |
Drugs - Testing | |
Generic drugs | |
Medical instruments and apparatus - Safety regulations | |
Soggetto geografico: | United States |
Soggetto genere / forma: | Legislative hearings. |
Rules. | |
Note generali: | "Serial no. 115-27." |
Altri titoli varianti: | Antitrust concerns and the FDA approval process |
Titolo autorizzato: | Antitrust concerns and the FDA approval process |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910709758903321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |